A study by Ahn et al (119) reported that ginsenoside Rf can decrease the production of IL-1β, IL-6, TNF-a, NO, and ROS, mediators that are highly activated in IBD, in TNF-α stimulated intestinal epithelial cells and macrophages. The gene discussed is IL1B; the disease is inflammatory bowel disease.